Korean Medication Algorithm for Schizophrenia 2019, Second Revision: Treatment of Psychotic Symptoms [0.03%]
2019年韩国精神分裂症治疗用药指南（第二版）——精神病性症状的治疗
Jung Suk Lee,Je-Yeon Yun,Shi Hyun Kang et al.
Jung Suk Lee et al.
Objective: In 2001, the Korean College of Neuropsychopharmacology and the Korean Society for Schizophrenia Research developed the Korean Medication Algorithm Project for Schizophrenia (KMAP-SPR 2001, revised 2006) through...
A Neurofeedback Protocol for Executive Function to Reduce Depression and Rumination: A Controlled Study [0.03%]
一种针对执行功能的神经反馈方案以减少抑郁和反刍思维：一项控制研究
Sheng-Hsiang Yu,Chao-Yuan Tseng,Wei-Lun Lin
Sheng-Hsiang Yu
Objective: Rumination is a maladaptive emotional-regulation strategy that is strongly associated with depression. Impaired executive function can lead to difficulties in disengaging from rumination, thus exacerbating depr...
Empathy and Social Attribution Skills Moderate the Relationship between Temporal Lobe Volume and Facial Expression Recognition Ability in Schizophrenia [0.03%]
共情和社会归属能力在颞叶体积和精神分裂症患者面部表情识别之间的关系中起调节作用
Minjee Jung,Seung Yeon Baik,Yourim Kim et al.
Minjee Jung et al.
Objective: While impaired facial expression recognition has been closely associated with reduced temporal lobe volume in patients with schizophrenia, this study aimed at examining whether empathy and social attribution af...
Improving Therapeutic Interventions of Schizophrenia with Advances in Stem Cell Technology [0.03%]
基于干细胞技术的 schizophrenia 治疗干预研究进展
José Andrés Espejo Oltra
José Andrés Espejo Oltra
Although historic documents posit schizophrenia to the beginnings of mankind, its diagnosis remains poorly defined, currently relying on unspecific clinical symptoms; and controversies still maintain its origin under intense debate. This re...
A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects [0.03%]
评估不同类型焦虑和抗焦虑效应的行为检测方法综述
Himanshu;Dharmila;Deepa Sarkar;Nutan
Himanshu;Dharmila;Deepa Sarkar;Nutan
Behavioral tests are very useful to understand the Neuro-psychotic disease and also helpful in finding the treatment of the particular disease. Nowadays various tests are available to evaluate the anxiolytics effect of a new entity or even ...
High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders [0.03%]
自闭症谱系障碍儿童血清中高水平的100β蛋白、神经元特异性烯醇化酶、Tau、活性半胱天冬酶-3、M30和M65检测
Hamza Ayaydın,Adnan Kirmit,Hakim Çelik et al.
Hamza Ayaydın et al.
Objective: The purpose of this study was therefore to investigate whether neuronal, axonal, and glial cell markers (Neuron-specific enolase [NSE], tau, serum 100 beta protein [S100B], respectively) and apoptosis markers (...
Gynecomastia: A Rare Adverse Effect of Methylphenidate in an Adolescent Boy [0.03%]
麻黄素诱发的一例青春期男孩乳糜肿胩病例报告
Ali Karayagmurlu,Ayse Tugce Varli,Murat Coskun
Ali Karayagmurlu
Gynecomastia is a benign condition developing in association with localized fat deposition and glandular tissue proliferation in the breast in males, and characterized by breast growth. Drug is one of the most important factors in the etiol...
Successful Electroconvulsive Therapy for a 74-year-old Female with Major Depressive Disorder and Tardive Tremor: A Case Report and Literature Review [0.03%]
氯氮平引起的迟发性震颤抑郁症患者经电休克治疗后症状缓解——一例伴有迟发性震颤的重度抑郁障碍患者的电休克治疗案例及文献回顾
Jia-Yin Yeh,Nien-Mu Chiu,Yung-Yee Chang et al.
Jia-Yin Yeh et al.
Tardive tremor is an infrequently form of tardive syndrome that is developed from prolonged treatment with dopamine receptor blocking agents. This condition presents as a prominent tremor that may cause significant distress but currently la...
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine [0.03%]
atomoxetine 治疗下甲基苯丙胺诱发的儿童舞蹈症加重症状缓解病例报告
Ozalp Ekinci,Cemre Yaşöz,Selin Ayşe İpek Baş et al.
Ozalp Ekinci et al.
Choreiform movements have been reported with stimulant medications, especially in adults. There is only limited evidence on the management of such reactions in children with attention deficit hyperactivity disorder. Hereby, we present the e...
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors [0.03%]
血清素能药物所致神经综合征的风险及对策
Stanley N Caroff
Stanley N Caroff
Objective: Vesicular monoamine transporter-2 (VMAT2) inhibitors have been proven to be effective for the treatment of tardive dyskinesia and their use is likely to increase. The evidence base of published clinical reports...